Morgan Stanley Merck & Co., Inc. Transaction History
Morgan Stanley
- $1.49 Trillion
- Q2 2025
A detailed history of Morgan Stanley transactions in Merck & Co., Inc. stock. As of the latest transaction made, Morgan Stanley holds 44,200,694 shares of MRK stock, worth $3.66 Billion. This represents 0.24% of its overall portfolio holdings.
Number of Shares
44,200,694
Previous 43,114,452
2.52%
Holding current value
$3.66 Billion
Previous $3.87 Billion
9.59%
% of portfolio
0.24%
Previous 0.28%
Shares
24 transactions
Others Institutions Holding MRK
# of Institutions
3,841Shares Held
1.96BCall Options Held
29.2MPut Options Held
30M-
Vanguard Group Inc Valley Forge, PA253MShares$20.9 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY207MShares$17.2 Billion0.59% of portfolio
-
State Street Corp Boston, MA118MShares$9.81 Billion0.36% of portfolio
-
Wellington Management Group LLP Boston, MA76.9MShares$6.36 Billion1.15% of portfolio
-
Geode Capital Management, LLC Boston, MA59MShares$4.88 Billion0.34% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $210B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...